Endocrinology
News
Selenium Supplementation Shows Thyroid Benefits
Systematic review suggests selenium supplements may help patients with Hashimoto thyroiditis.
News
Surveillance for 21 Possible Effects of Endocrine Disruptors
French public health agency classified 21 health effects as a priority for surveillance, including metabolic, reproductive effects.
News from the FDA/CDC
Vibrating Belt Receives Approval to Help Women With Osteopenia Keep Bone Strength
The device was the first approved nonpharmacologic treatment for postmenopausal women with low bone density. It has not been tested for ability to...
News from the FDA/CDC
Hypocalcemia Risk Warning Added to Osteoporosis Drug
Based on a completed data review, the agency concluded that denosumab increases the risk for severe hypocalcemia in patients with chronic kidney...
News
Testosterone Supplements: Overcoming Current Misconceptions
Low testosterone is commonly underdiagnosed and undertreated in France.
News
Prostate Risks Similar for Testosterone Therapy and Placebo
Uncertainty and concern exist about a link between prostate cancer risk and testosterone levels.
News
EHR Tool Enhances Primary Aldosteronism Screening in Hypertensive Patients
Use of a best-practice advisory embedded in an EHR led to increased rates of screening for PA, particularly among primary care physicians.
News
Direct Measurement of T3 Is Likely Vital, Say Researchers
T3 may be an important test to identify subclinical changes in thyroid function, say researchers.
News
Why GLP-1 Drugs Stop Working, and What to Do About It
If a patient plateaus on a GLP-1 drug, it may work to add additional drugs that have different brain targets.
News
Ozempic is Appealing, but Not Cost-Effective, for Obesity Treatment
Surgical and endoscopic options to treat obesity are cost effective, but not the pharmacological intervention semaglutide.